advancements of targeted therapy for egfr mutations in nsclc
Published 1 year ago • 469 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
22:49
grace targeted therapies lung cancer 2021 - management of uncommon egfr mutations including exon 20
-
3:46
q&a: how do oncologists approach compound egfr mutations? - targeted therapies in lung cancer 2023
-
2:43
post-osimertinib treatment options for egfr nsclc - targeted therapies in lung cancer 2023
-
4:09
egfr mutations: uncommon treatment & insurance complications -2022 program: targeted therapies forum
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
5:52
case based panel discussion - egfr - exon 20 mutation, treatment, targeted therapy, clinical trials
-
7:35
treatment for patients with egfr nsclc - leading developments & current questions in lung cancer
-
6:13
evolving treatment for nsclc: targeted therapies - 2022 program: targeted therapies forum
-
7:48
should avastin be added to egfr tki therapy for egfr mutation-positive nsclc?
-
1:22:21
egfr breakout video targeted therapies 2017
-
16:03
grace targeted therapies lung cancer 2021 -the role of chemotherapy in driver positive patients
-
4:02
egfr resisters: an advocacy group - targeted therapies in lung cancer 2023
-
3:35
grace targeted therapies lung cancer 2021 - current treatment options for egfr fusions e.g. rad 51